|
|||||
|
|
Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate‐risk disease |
|
| Authors: | Florence K. Keane MD Ming‐Hui Chen PhD Danjie Zhang PhD Brian J. Moran MD Michelle H. Braccioforte MPH Anthony V. D'Amico MD |
| Affiliation: | 1. Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts;2. Department of Statistics, University of Connecticut, Storrs, Connecticut;3. Prostate Cancer Foundation of Chicago, Westmont, Illinois;4. Department of Radiation Oncology, Dana‐Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts |
| Abstract: | |
| Keywords: | prostate cancer intermediate‐risk prostate cancer androgen deprivation therapy brachytherapy external‐beam radiotherapy unfavorable intermediate‐risk prostate cancer favorable intermediate‐risk prostate cancer |